Nodthera Limited
Clinical trials sponsored by Nodthera Limited, explained in plain language.
-
New pill aims to boost weight loss in obese adults with diabetes
Disease control OngoingThis study tests an experimental drug called NT-0796 in 176 adults with obesity, some of whom also have type 2 diabetes. Participants take the drug or a placebo alongside a reduced-calorie diet and increased physical activity for 6 months. The goal is to see if the drug helps red…
Phase: PHASE2 • Sponsor: NodThera Limited • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New combo pill could boost weight loss and fight inflammation
Disease control OngoingThis study tests whether adding an experimental drug (NT-0796) to semaglutide (a weight-loss medication), along with diet and exercise, helps people with obesity lose more weight and reduce inflammation. About 82 adults with a BMI of 30 or higher will receive either the combinati…
Phase: PHASE2 • Sponsor: NodThera Limited • Aim: Disease control
Last updated May 13, 2026 16:03 UTC